Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma. - Wikidata - wikimedia - TriplyDB

Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma.

Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma.

http://www.wikidata.org/entity/Q33348197

about

Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis Origin and molecular pathogenesis of ovarian high-grade serous carcinoma Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer Integrated genomic analyses of ovarian carcinoma Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence Identification of ovarian cancer driver genes by using module network integration of multi-omics data.Glucocorticoid-induced reversal of interleukin-1β-stimulated inflammatory gene expression in human oviductal cells.Gross genomic alterations and gene expression profiles of high- grade serous carcinoma of the ovary with and without BRCA1 inactivation.Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers.Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics.Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis.Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironment.Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity.Coming into focus: the nonovarian origins of ovarian cancer.A Novel Subset of Human Tumors That Simultaneously Overexpress Multiple E2F-responsive Genes Found in Breast, Ovarian, and Prostate Cancers Pathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implications Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and high-grade serous carcinoma Stem cell-like gene expression in ovarian cancer predicts type II subtype and prognosis The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis.In vitro three-dimensional modeling of fallopian tube secretory epithelial cells.Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomes.Tumor microenvironment-associated modifications of alternative splicing.Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.Coevolution reveals a network of human proteins originating with multicellularity.The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer.Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis NF-YA underlies EZH2 upregulation and is essential for proliferation of human epithelial ovarian cancer cells.Salpingectomy as standard at hysterectomy? A Danish cohort study, 1977-2010.Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer.The oviductal transcriptome is influenced by a local ovarian effect in the sow.FGF18 as a prognostic and therapeutic biomarker in ovarian cancer.BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress BRCA and Early Events in the Development of Serous Ovarian Cancer.Effect of menopause on hormonal receptors in ampullae of the fallopian tube with a special reference to the p53 signature.Oviductal secretions: will they be key factors for the future ARTs?The oviduct: functional genomic and proteomic approach.Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.Harnessing the potential of lipid-based nanomedicines for type-specific ovarian cancer treatments.

P2860

Q26747279-2708A2FC-A135-44B1-A705-85BBE0858B68 Q26822545-9BE895C4-1E03-45FA-901C-5B56A5E3C32E Q26852698-561298BF-816B-465B-B7B3-13C2BE6989E7 Q27009306-3CC51E6F-0342-4096-B95B-CE4E162C20A4 Q27860518-6C477351-702B-4EE3-B3D6-16DABD693DF3 Q30250107-B015C8AE-5F4E-4B5A-A223-DAFA5EEA2BDF Q30753342-B2E7570D-78AD-4AA1-B88B-8B0F30FF8174 Q33645478-31D4CEA1-463F-4615-8496-892DFA29D824 Q33693203-E3762BC0-0CF6-41A2-94CE-6E4D06B6141C Q33775466-F1E9A980-B546-4E19-B0A1-5A181A38189F Q33815261-7FF6A7EB-0174-443C-BD10-FE1D32F85DDD Q33851325-FBD86C88-2775-4A7B-948F-249AD28B4E92 Q33888942-564441DA-B2C5-4326-B7B6-D6734FBD8DE1 Q34097070-8E1F09D9-8938-479A-B863-A10270782FE7 Q34225781-5B1CABBD-EF26-4869-8B7B-6863872A26C8 Q34378112-11B2CEF3-E664-4B7C-835C-65ECF4B977EE Q34456552-291D6CEC-8E59-4B9B-B32C-5B2113570F9C Q34501822-936D455D-0061-4D86-B681-41B0307512BF Q34595670-FAD1FBE6-2563-49AB-85E1-36DD4F4BDE62 Q34639023-96A7C121-A3FC-464F-8616-777DFBC04610 Q34662610-2C224C4D-44CD-4725-8957-32F6D595E66B Q35000194-D10CC5A4-9AB7-4CF2-9A17-4A70EB10EC54 Q35058483-1CE900A8-EAD1-48CC-823F-B173C9010412 Q35066327-F06FEEFB-3669-4D88-8F77-111AD2173D17 Q35749439-25564EF0-C6A3-41EE-A8FF-BA2E635B7A0F Q36543191-C6BF76C8-65E8-497B-84BA-120D18D42CB7 Q36588945-7C79CFCD-73F8-47B0-9843-370C5BADA4D2 Q36652107-A4CCB83C-EED4-4037-9BDF-E20BF08B7FF4 Q36780759-8D5341FE-BD3A-4FB3-ABB0-3B3A35E22ACF Q36939176-499E92F6-6E62-4D17-B5B4-F682EBA37296 Q37040827-35EE494F-6696-43D5-A3C2-046C5B2C245A Q37119477-C146B70E-8243-4C1C-9F2A-186F9D49DC84 Q37200903-E6EDDA46-4A88-4A78-91E3-BC0773501897 Q37330894-63B13883-DC5B-4040-A867-8FA60D672E80 Q37513137-061D7D56-B85E-4CB7-BE64-CA3D1C7F51A3 Q37745666-37858242-A763-44B4-966A-F2A29AB1CA7E Q37768290-E0329C84-71F4-4CF5-BF94-7732D21BA867 Q38017289-527EA203-67E2-429E-8E80-D28A411A3C2F Q38067435-CCCE59FC-07CF-4D36-A9EE-FA63EFBA2587 Q38205584-0EA9C9E9-B09B-490E-BCC0-E75F39ACBD8E

P2860

Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma.

http://www.wikidata.org/entity/Q33348197

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Gene expression profiles of lu ...... e high-grade serous carcinoma.

@ast

Gene expression profiles of lu ...... e high-grade serous carcinoma.

@en

type

label

Gene expression profiles of lu ...... e high-grade serous carcinoma.

@ast

Gene expression profiles of lu ...... e high-grade serous carcinoma.

@en

prefLabel

Gene expression profiles of lu ...... e high-grade serous carcinoma.

@ast

Gene expression profiles of lu ...... e high-grade serous carcinoma.

@en

P1433

Q33348197-FDAE18E7-79F4-4AA5-9D8C-3451C0A989B1

P1476

Q33348197-8A374D23-3E8B-4123-B99C-B6A6C0D77FE8

P2093

Q33348197-2D18BD85-0C5F-40EA-81AF-EA788C279330

Q33348197-2E740B55-B207-4600-B561-D65F3641C858

Q33348197-56A85188-2B7B-4471-9772-E6781C81304B

Q33348197-AD28F68C-727D-455C-A06B-14D8F786F441

Q33348197-C0E9E2C0-3AC3-4173-B605-20349BEBF428

Q33348197-F15F3227-ECD9-46A1-81AA-8F1A9026DC04

P304

Q33348197-B79739B4-D580-4B49-87B9-89F13B0AEC80

P31

Q33348197-E55D5ACE-6647-484C-BFF0-72FA1B628429

P356

Q33348197-5E2109AB-F72F-42FB-AF98-745966B31D20

P407

Q33348197-EF249FF4-D6DF-4997-A150-A14A17A4BFCA

P433

Q33348197-07023401-6D4D-41AB-899B-FC115F27B10C

P478

Q33348197-C0869275-B4C0-4903-B572-6445AC381061

P50

Q33348197-08C7AC70-5755-4277-BB67-2F35F1ED65A0

P577

Q33348197-56C6F0F3-7225-48AE-9DBF-124E332D2F99

P698

Q33348197-FF5B651A-E9E6-4A9A-A320-186E06F5992A

P921

Q33348197-DDA68561-9869-4023-81D2-D6670B91CA1A

P356

1078-0432.CCR-07-4959

P1433

Clinical Cancer Research

P1476

Gene expression profiles of lu ...... e high-grade serous carcinoma.

@en

P2093

Alicia A Tone

http://www.w3.org/2001/XMLSchema#string

Barry Rosen

http://www.w3.org/2001/XMLSchema#string

Heather Begley

http://www.w3.org/2001/XMLSchema#string

Joan Murphy

http://www.w3.org/2001/XMLSchema#string

Monika Sharma

http://www.w3.org/2001/XMLSchema#string

Patricia A Shaw

http://www.w3.org/2001/XMLSchema#string

P304

4067-4078

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-07-4959

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Theodore J Brown

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18593983

http://www.w3.org/2001/XMLSchema#string

P921